A detailed history of Riverpark Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Riverpark Capital Management LLC holds 2,354 shares of LLY stock, worth $1.9 Million. This represents 2.82% of its overall portfolio holdings.

Number of Shares
2,354
Previous 2,181 7.93%
Holding current value
$1.9 Million
Previous $1.7 Million 25.65%
% of portfolio
2.82%
Previous 2.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $125,402 - $157,263
173 Added 7.93%
2,354 $2.13 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $271,819 - $363,656
459 Added 26.66%
2,181 $1.7 Million
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $386,014 - $455,060
735 Added 74.47%
1,722 $1 Million
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $429,048 - $591,509
987 New
987 $530,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Riverpark Capital Management LLC Portfolio

Follow Riverpark Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverpark Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverpark Capital Management LLC with notifications on news.